Compare CVS Health Corp (CVS) vs JPMorgan Nasdaq Equity Premium Income ETF (JEPQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs JPMorgan Nasdaq Equity Premium Income ETF — how do they compare? CVS Health Corp trades at $93.39 (market cap $119.58B), while JPMorgan Nasdaq Equity Premium Income ETF trades at $59.89. The key difference: CVS Health Corp pays a 2.84% dividend while JPMorgan Nasdaq Equity Premium Income ETF pays none, and JPMorgan Nasdaq Equity Premium Income ETF is trading nearer its 52-week high, CVS Health Corp nearer its low. Which is the better fit depends on your goals.
| CVS | JEPQ | |
|---|---|---|
Market Cap | $119.58B | — |
Sector | Health | Income / Options Overlay |
52-Week High | $110.60 | $61.46 |
52-Week Low | $65.51 | $53.77 |
Enterprise Value | $181.93B | — |
Dividend Yield | 2.84% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About JPMorgan Nasdaq Equity Premium Income ETF
JEPQ seeks to provide monthly income and exposure to the Nasdaq-100 Index with less volatility. It uses a methodology that combines high-growth tech stocks with an options strategy to capture income.
Read more on JEPQ →
